Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Leading Diabetic Footwear End Use Markets Databank
... to 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment ... Read More
-
Europe Diabetic Footwear Market Databank
... Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is anticipated ... Read More
-
Leading Diabetic Footwear Country Markets Databank
... 2029. North America is expected to be the highest contributor to this market, with $2,250.6 Million in 2020, and is anticipated to reach $3,867.7 Million by 2029, registering a CAGR of 6.24%. Asia-Pacific is anticipated ... Read More
-
Leading Diabetic Footwear Product Markets Databank
... 2029. Shoes segment is expected to be the highest contributor to this market, with $2,508.8 Million in 2020, and is anticipated to reach $4,260.1 Million by 2029, registering a CAGR of 6.10%. Sandals segment is ... Read More
-
North America Diabetic Footwear Market Databank
... 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is ... Read More
-
Latin America, Middle East & Africa Diabetic Footwear Market Databank
... 6.09% from 2021 to 2029. Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of ... Read More
-
Asia-Pacific Diabetic Footwear Market Databank
... Offline segment is expected to be the highest contributor to this market, with $4,863.4 Million in 2020, and is anticipated to reach $8,193.4 Million by 2029, registering a CAGR of 6.01%. Online segment is anticipated ... Read More
-
Insulin Resistance Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Insulin Resistance (Metabolic Disorders) pipeline landscape. Insulin resistance (IR) is a condition in which the body's cells become resistant ... Read More
-
Diabetic Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type ... Read More
-
Diabetic Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Macular Edema (Metabolic Disorders) pipeline landscape. Diabetic macular edema (DME) occurs when blood vessels in the ... Read More
-
Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030
... SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Insulin Pens ... Read More
-
Dual Chamber Pre-Filled Syringes Market Report 2022-2032
... and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Dual Chamber syringes have a number of ... Read More
-
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Insulin Pens Market - Global Outlook & Forecast 2022-2027
... Insulin Pens in the forecast period due to its long-term cost-effectiveness and other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens. Other than high-income countries with full diabetes insurance ... Read More
-
Global Drug Discovery Market Forecast 2022-2030
... the technological advancements are the primary factors propelling the market growth. MARKET INSIGHTS Drug discovery entails identifying the potential new medicines in a vast range of scientific disciplines like pharmacology, chemistry, and biology. The drug ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028
... Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028 The clinical nutrition market ... Read More
-
Insulin Drugs Global Market Report 2022
... drugs market. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the market is being affected by the coronavirus and how it ... Read More
-
MENA Nutraceuticals Market, by Product type (Calcium Supplement Tablets and Gummies, Probiotics Supplement Tablets & Capsules, Collagen Peptide Powder Jar or Sachet, Iron in Tablet and Gummies & Syrup, Folic Acid Tablet, Pyridoxine Tablet, Rocket Seed Oil in Soft Gel, Prenatal Vitamin in Tablet and Gummies, Chaste Berry in Powder and Tablet and Capsule, Natural Eggshell Membrane in Capsule, Melatonin in Tablet, Vitamin C in Tablet, Inositol in Tablet, Whey Protein in Powder and Sachet, Biotin in Tablet, Hypericum perforatum Extract in Capsule, Vitamin D3 in Soft Gel Capsule and Gummies, Omega 3 in Soft Gel and Gummies, Omega 3 Plus Multivitamin in Soft Gel, Gummies Natural Eggshell Membrane in Capsule, CBD (CBD Tinctures, Capsules & Soft gels, CBD Gummies, Others), and Others), by Application (Cancer, Diabetes, Heart Disorders, Hypertension, Obesity, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Convenience Store, Hypermarket/ Supermarket and Online Phar
... Seed Oil in Soft Gel, Prenatal Vitamin in Tablet and Gummies, Chaste Berry in Powder and Tablet and Capsule, Natural Eggshell Membrane in Capsule, Melatonin in Tablet, Vitamin C in Tablet, Inositol in Tablet, Whey ... Read More
-
Pharmaceutical Drugs Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; O
... 2021: Covid 19 Impact and Recovery The global pharmaceutical drugs market grew from $771.16 billion in 2015 to $975 billion in 2020 at a CAGR of 4.80%. The global pharmaceutical drugs market is expected to ... Read More
-
mHealth Market Forecast to 2028 - COVID-19 Impact and Analysis - by Service (Remote Monitoring, Diagnosis, Treatment, Health Support, Fitness & Wellness, and Other Services), Devices (Insulin Pump, BP Monitor, Glucose Monitor, Personal Pulse Oximeter, and Other Devices), and End User (Mobile Operators, Devices Vendors, Health Providers, and Others), and Geography
... and Other Devices), and End User (Mobile Operators, Devices Vendors, Health Providers, and Others), and Geography The mHealth market is projected to reach US$ 410.39 billion by 2028 from US$ 70.83 billion in 2021; it ... Read More
-
In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2026
... to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric ... Read More
-
U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The U.S. clinical ... Read More
-
Active Pharmaceutical Ingredient Market: Segmented By Type (Innovative and Generic); By Type of Synthesis (Synthetic and Biotech); By Application (Communicable Diseases, Oncology, Cardiovascular Diseases, Diabetes, Pain Management, Chronic Respiratory Diseases, and Other) and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030
... Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030 Global Active Pharmaceutical Ingredient to surpass USD 336 billion by 2030 from USD 188 billion in 2020 at a CAGR 6.23% ... Read More
-
Diabetes Drug Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
... indicated by high blood sugar levels. It is caused by a malfunction in the pancreas, which secretes insulin. Besides, diabetes is also referred to as diabetes mellitus. High blood sugar levels cause thirst, hunger, and ... Read More
Research Assistance
